Dopamine Receptor
Dopamine receptors (DR) are members of G protein-coupled receptors superfamily. There are 5 subtypes (D1, D2, D3, D4, D5) of DR which mediate the functions of dopamine in central nervous system for control of locomotion, cognition, and emotion etc.
Products Related to Dopamine Receptor(300)
- GC10105Amantadine HClCAS: 665-66-7Purity: >98.00%
Amantadine (1-Adamantanamine) hydrochloride is an orally avtive and potent antiviral agent with activity against influenza A viruses.
- GC11186BrexpiprazoleCAS: 913611-97-9Purity: >97.00%
Brexpiprazole, an oral atypical antipsychotic agent, is a potent partial agonist of 5-HT1A (K i =0.12nM) and dopamine D2L (K i =0.3nM) receptors, and an antagonist of 5-HT2A receptor (K i =0.47nM).
- GC14216Chlorpromazine HClCAS: 69-09-0Purity: >99.50%
Chlorpromazine HCl is an orally effective, blood-brain-permeable phenothiazine antipsychotic that can effectively antagonize D2 dopamine receptors and 5-HT 2A and has a strong sedative effect.
- GC16783Pramipexole 2HCl MonohydrateCAS: 191217-81-9Purity: >98.00%
Pramipexole 2HCl Monohydrate is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively.
- GC16891Quetiapine FumarateCAS: 111974-72-2Purity: >98.00%
Quetiapine Fumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor.
- GC17184AmbrisentanCAS: 177036-94-1Purity: >99.50%
Ambrisentan is an orally active, highly selective antagonist of endothelin receptor ETA-selective antagonist, with an IC 50 value of 0.6nM.
- GC17599HaloperidolCAS: 52-86-8Purity: >98.00%
Haloperidol is a classic antipsychotic and dopamine D2-like receptor antagonist, as well as an ion channel inhibitor that inhibits a variety of ion channels, such as G-protein-activated inwardly rectifying potassium channels, calcium-activated potassium channels, HERG and HEAG potassium channels, as well as L-, N- and P-type calcium channels.
- GC17741Vanoxerine dihydrochlorideCAS: 67469-78-7Purity: >98.00%
potent and selective DRI (Dopamine reuptake inhibitor)
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10105 | Amantadine HCl | 665-66-7 | >98.00% | |
Amantadine (1-Adamantanamine) hydrochloride is an orally avtive and potent antiviral agent with activity against influenza A viruses. | ||||
| GC10112 | Paliperidone | 144598-75-4 | >99.50% | |
Dopamine receptor antagonist | ||||
| GC10117 | Aripiprazole | 129722-12-9 | >99.50% | |
5-HT receptor partial agonist | ||||
| GC10144 | Domperidone | 57808-66-9 | >99.50% | |
Drug for gastroparesis | ||||
| GC11028 | Dopamine HCl | 62-31-7 | >98.50% | |
Dopamine D1-5 receptors agonist | ||||
| GC11182 | LY404039 | 635318-11-5 | >98.00% | |
MGlu2 and mGlu3 receptors agonist | ||||
| GC11186 | Brexpiprazole | 913611-97-9 | >97.00% | |
Brexpiprazole, an oral atypical antipsychotic agent, is a potent partial agonist of 5-HT1A (K i =0.12nM) and dopamine D2L (K i =0.3nM) receptors, and an antagonist of 5-HT2A receptor (K i =0.47nM). | ||||
| GC11506 | Haloperidol hydrochloride | 1511-16-6 | >98% | |
Antipsychotic drug | ||||
| GC11960 | Pramipexole | 104632-26-0 | >99.50% | |
Dopamine agonist | ||||
| GC12610 | Amisulpride | 71675-85-9 | >99.50% | |
Dopamine D2/D3 receptor antagonist | ||||
| GC13322 | Vanoxerine | 67469-69-6 | >98% | |
potent and selective DRI (Dopamine reuptake inhibitor) | ||||
| GC13853 | GBR 12935 dihydrochloride | 67469-81-2 | >98.00% | |
dopamine reuptake inhibitor | ||||
| GC14216 | Chlorpromazine HCl | 69-09-0 | >99.50% | |
Chlorpromazine HCl is an orally effective, blood-brain-permeable phenothiazine antipsychotic that can effectively antagonize D2 dopamine receptors and 5-HT 2A and has a strong sedative effect. | ||||
| GC14759 | Fenoldopam | 67227-56-9 | >98% | |
D1-like dopamine receptor partial agonist | ||||
| GC15095 | Levodopa | 59-92-7 | >99.00% | |
Levodopa (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. | ||||
| GC15312 | Chlorprothixene | 113-59-7 | >99.00% | |
Dopamine receptor antagonist | ||||
| GC15470 | Levosulpiride | 23672-07-3 | >99.50% | |
Antipsychotic drug | ||||
| GC16615 | Pergolide mesylate | 66104-23-2 | >99.50% | |
Dopaminergic agonist | ||||
| GC16783 | Pramipexole 2HCl Monohydrate | 191217-81-9 | >98.00% | |
Pramipexole 2HCl Monohydrate is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. | ||||
| GC16891 | Quetiapine Fumarate | 111974-72-2 | >98.00% | |
Quetiapine Fumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. | ||||
| GC17184 | Ambrisentan | 177036-94-1 | >99.50% | |
Ambrisentan is an orally active, highly selective antagonist of endothelin receptor ETA-selective antagonist, with an IC 50 value of 0.6nM. | ||||
| GC17599 | Haloperidol | 52-86-8 | >98.00% | |
Haloperidol is a classic antipsychotic and dopamine D2-like receptor antagonist, as well as an ion channel inhibitor that inhibits a variety of ion channels, such as G-protein-activated inwardly rectifying potassium channels, calcium-activated potassium channels, HERG and HEAG potassium channels, as well as L-, N- and P-type calcium channels. | ||||
| GC17600 | PD128907 HCl | 112960-16-4 | >98% | |
Potent and selective dopamine D3 receptor agonist | ||||
| GC17741 | Vanoxerine dihydrochloride | 67469-78-7 | >98.00% | |
potent and selective DRI (Dopamine reuptake inhibitor) | ||||